AUL
WVE icon

AlphaGrep UK Ltd’s Wave Life Sciences WVE Stock Holding History

AlphaGrep UK Ltd’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$157K Buy
+21,614
New +$282K 0.05% 740

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $602M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

AlphaGrep UK Ltd's WVE Position: Q1 2026 in Review

AlphaGrep UK Ltd opened a new position in Wave Life Sciences (WVE) in Q1 2026: 21,614 shares worth $157K. The stake represents 0.05% of the portfolio and ranks #740 among its holdings.

232 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • AlphaGrep UK Ltd held 21,614 shares of Wave Life Sciences worth $157K as of Q1 2026.
  • Wave Life Sciences was a new AlphaGrep UK Ltd position in Q1 2026.
  • Wave Life Sciences made up 0.05% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #740 holding.
  • 232 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.